Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iradimed (IRMD) Deferred Taxes (2016 - 2025)

Iradimed (IRMD) has disclosed Deferred Taxes for 13 consecutive years, with -$134872.0 as the latest value for Q3 2025.

  • On a quarterly basis, Deferred Taxes fell 7.19% to -$134872.0 in Q3 2025 year-over-year; TTM through Sep 2025 was -$292164.0, a 144.21% decrease, with the full-year FY2024 number at $697652.0, down 40.47% from a year prior.
  • Deferred Taxes was -$134872.0 for Q3 2025 at Iradimed, down from -$133533.0 in the prior quarter.
  • In the past five years, Deferred Taxes ranged from a high of $1.6 million in Q2 2024 to a low of -$917373.0 in Q1 2024.
  • A 5-year average of $46887.8 and a median of -$78656.0 in 2023 define the central range for Deferred Taxes.
  • Peak YoY movement for Deferred Taxes: skyrocketed 1131.55% in 2023, then crashed 1066.31% in 2024.
  • Iradimed's Deferred Taxes stood at -$109512.0 in 2021, then crashed by 159.54% to -$284230.0 in 2022, then skyrocketed by 124.29% to $69042.0 in 2023, then soared by 53.27% to $105823.0 in 2024, then crashed by 227.45% to -$134872.0 in 2025.
  • Per Business Quant, the three most recent readings for IRMD's Deferred Taxes are -$134872.0 (Q3 2025), -$133533.0 (Q2 2025), and -$129582.0 (Q1 2025).